Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Mongiat-Artus

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
European Urology|March 11, 2008
Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 Pierre Mongiat-Artus
European Urology|August 22, 2008
Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrumPierre Mongiat-Artus
La Revue Du Praticien|February 11, 2015
[Oncogenetic consultation for urothelial cancer of the upper urinary tract]Pierre Mongiat-Artus
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Double kidney transplantation]Pierre Mongiat-Artus
La Revue Du Praticien|May 21, 2013
[Castration in the treatment of locally advanced or metastatic prostate cancer]Pierre Mongiat-Artus
European Urology|May 13, 2008
Re: androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortalityPierre Mongiat-Artus
Expert Opinion on Pharmacotherapy|October 6, 2004
Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancerPierre Mongiat-Artus, Pierre Teillac
European Urology|December 20, 2016
Corrigendum to "Re: Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort with Localized Prostate Cancer" [Eur Urol 2010;58:179-80]Guillaume Ploussard, Pierre Mongiat-Artus
European Urology|August 3, 2011
Words of wisdom: Re: Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 studyFrançois Rozet, Pierre Mongiat-Artus
Presse Medicale (Paris, France : 1983)|October 22, 2017
[Management of prostate cancer in patients older than 75 years]Pierre Mongiat-Artus, Danièle Avenin
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
European Urology|March 11, 2008
Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 Pierre Mongiat-Artus
European Urology|August 22, 2008
Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrumPierre Mongiat-Artus
La Revue Du Praticien|February 11, 2015
[Oncogenetic consultation for urothelial cancer of the upper urinary tract]Pierre Mongiat-Artus
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Double kidney transplantation]Pierre Mongiat-Artus
La Revue Du Praticien|May 21, 2013
[Castration in the treatment of locally advanced or metastatic prostate cancer]Pierre Mongiat-Artus
European Urology|May 13, 2008
Re: androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortalityPierre Mongiat-Artus
Expert Opinion on Pharmacotherapy|October 6, 2004
Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancerPierre Mongiat-Artus, Pierre Teillac
European Urology|December 20, 2016
Corrigendum to "Re: Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort with Localized Prostate Cancer" [Eur Urol 2010;58:179-80]Guillaume Ploussard, Pierre Mongiat-Artus
European Urology|August 3, 2011
Words of wisdom: Re: Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 studyFrançois Rozet, Pierre Mongiat-Artus
Presse Medicale (Paris, France : 1983)|October 22, 2017
[Management of prostate cancer in patients older than 75 years]Pierre Mongiat-Artus, Danièle Avenin
Pageof 9